Apixaban - Bristol-Myers Squibb/Pfizer
At a glance
- Drug Originator Bristol-Myers Squibb
- Drug Licenced by Pfizer
- Drug Class 2 ring heterocyclic compounds; Amides; Anticoagulants; Antithrombotics; Cardiovascular therapies; Lactams; Phenyl ethers; Pyrazoles; Pyridones; Small molecules; Vascular disorder therapies
- Mechanism of Action Factor Xa inhibitors
- USA Patent Applicants BRISTOL MYERS SQUIBB
- USA Patents 14
- NDAs 1
- International Patents 171
- Patent Applications 3,007
Table of Contents
Disclaimer